Dow Jones

38,798.99

-0.22%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

POTP

Point Therapeutics (MM) (POTP)

Point Therapeutics (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:POTP

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
12/02/2008	15:15	PR Newswire (US)	DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger	NASDAQ:POTP	Point Therapeutics (MM)
12/02/2008	14:02	Edgar (US Regulatory)	Point Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:POTP	Point Therapeutics (MM)
11/02/2008	13:30	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
11/02/2008	08:00	Business Wire	Update on Point Therapeutics Merger with DARA BioSciences	NASDAQ:POTP	Point Therapeutics (MM)
08/02/2008	09:23	Edgar (US Regulatory)	Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)	NASDAQ:POTP	Point Therapeutics (MM)
04/02/2008	06:30	PR Newswire (US)	DARA BioSciences to Present at the ROTH Growth Stock Conference	NASDAQ:POTP	Point Therapeutics (MM)
29/01/2008	15:30	Business Wire	Point Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences Stockholders Approve Merger with Poin	NASDAQ:POTP	Point Therapeutics (MM)
10/01/2008	07:00	Business Wire	Point Therapeutics Receives Additional Notice of Non-Compliance from NASDAQ	NASDAQ:POTP	Point Therapeutics (MM)
27/12/2007	07:30	Business Wire	Point Therapeutics Announces Form S-4 Registration Statement Declared Effective by SEC; Special Meeting of Stockholders Set for	NASDAQ:POTP	Point Therapeutics (MM)
17/12/2007	16:12	Edgar (US Regulatory)	Point Therapeutics Inc - Registration Statement for securities to be issued in business combination transactions (S-4/A)	NASDAQ:POTP	Point Therapeutics (MM)
17/12/2007	07:30	Business Wire	NASDAQ Panel Grants Request of Point Therapeutics for Continued Listing on NASDAQ Capital Market	NASDAQ:POTP	Point Therapeutics (MM)
26/11/2007	06:13	Edgar (US Regulatory)	Point Therapeutics Inc - Securities Registration: Business Combination (S-4)	NASDAQ:POTP	Point Therapeutics (MM)
09/11/2007	08:38	Edgar (US Regulatory)	Point Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:POTP	Point Therapeutics (MM)
25/10/2007	06:00	PR Newswire (US)	DARA BioSciences, Inc. Announces New Board Chairman	NASDAQ:POTP	Point Therapeutics (MM)
17/10/2007	06:00	PR Newswire (US)	DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License Agreement	NASDAQ:POTP	Point Therapeutics (MM)
09/08/2007	15:01	Business Wire	Point Therapeutics Reports Second Quarter 2007 Financial Results	NASDAQ:POTP	Point Therapeutics (MM)
27/07/2007	06:30	Business Wire	Point Therapeutics Announces Further Management Reductions	NASDAQ:POTP	Point Therapeutics (MM)
12/07/2007	07:30	Business Wire	Point Therapeutics Update	NASDAQ:POTP	Point Therapeutics (MM)
31/05/2007	07:00	Business Wire	Point Therapeutics Reduces Costs by Cutting Work Force	NASDAQ:POTP	Point Therapeutics (MM)
21/05/2007	07:00	Business Wire	Talabostat Clinical Program Put on Clinical Hold by FDA	NASDAQ:POTP	Point Therapeutics (MM)
15/05/2007	09:02	Business Wire	CORRECTING and REPLACING Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta Stu	NASDAQ:POTP	Point Therapeutics (MM)
15/05/2007	07:01	Business Wire	Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta Study	NASDAQ:POTP	Point Therapeutics (MM)
10/05/2007	07:00	Business Wire	Point Therapeutics Reports First Quarter 2007 Financial Results	NASDAQ:POTP	Point Therapeutics (MM)
13/04/2007	07:00	Business Wire	Point Therapeutics Announces Preclinical Data Presentations at Upcoming American Association of Cancer Research Annual Meeting	NASDAQ:POTP	Point Therapeutics (MM)
26/03/2007	07:24	Business Wire	Point Therapeutics Announces Management Change and Additional Information In Compliance With NASDAQ Rules	NASDAQ:POTP	Point Therapeutics (MM)
16/03/2007	12:16	Business Wire	Point Therapeutics Reports Fourth Quarter and Year-End 2006 Financial Results	NASDAQ:POTP	Point Therapeutics (MM)
13/03/2007	07:30	Business Wire	Point Therapeutics Receives Letter from Nasdaq Citing Non-Compliance with Minimum Bid Price Rules	NASDAQ:POTP	Point Therapeutics (MM)
01/03/2007	06:25	Business Wire	Point Therapeutics Provides Clinical Update	NASDAQ:POTP	Point Therapeutics (MM)
24/01/2007	07:12	Business Wire	Point Therapeutics Announces Resignation of William Whelan from Board of Directors	NASDAQ:POTP	Point Therapeutics (MM)
12/01/2007	06:44	Business Wire	Point Therapeutics Provides Preliminary Results from Phase 2 Metastatic Pancreatic Cancer Study	NASDAQ:POTP	Point Therapeutics (MM)